View details of this raise on Seedstage

Greenwich, CT

Developing a cloud-based healthcare data platform that captures real-world clinical outcomes directly from providers and patients.

• Patented platform: Built to capture, aggregate, and correlate clinically and regulatorily significant health data.
• Multi-stakeholder value: Serves payers, manufacturers, providers, and researchers with proprietary datasets.
• Forward-looking tech stack: Includes AI, blockchain, and tokenization for scalability and security.
• Recurring revenue: Fast-growing client base with international reach and inherent network effects.
• Zero-to-one thesis: Focused on creating an entirely new healthcare data infrastructure from the ground up.

RegenMed is raising capital to scale its patented cloud-based platform that captures and correlates clinically significant, regulatorily compliant data directly from physicians and patients. This primary-source health data is used to build unbiased, coherent datasets that serve a variety of stakeholders including payers, manufacturers, providers, and researchers. The funds from this offering will support continued product development, expansion of client services, and further commercialization efforts. RegenMed’s strategy leverages modern technology and physician-centered processes to address inefficiencies in healthcare data infrastructure, aiming to improve outcomes, lower costs, and enhance equity across the healthcare ecosystem.

The company positions itself as a “zero to one” venture—one that is not simply improving existing processes but fundamentally reshaping the healthcare data market. RegenMed plans to integrate recursive AI models to support natural language data processing across medical conditions and procedures, and to incorporate blockchain technologies to enhance data security and incentivize health information sharing. With a recurring revenue base, growing international footprint, and strong network effects, RegenMed is well positioned for long-term growth. The company also intends to pursue monetization strategies that may include licensing its proprietary datasets and exploring tokenization of health records.

Company Info

RegenMed is building a platform to transform healthcare data by capturing real-world clinical outcomes directly from physicians and patients.

RegenMed is a New York-based healthcare data company building a cloud-based platform to capture, structure, and analyze real-world clinical outcomes from routine physician and patient interactions. Its patented system aggregates data across pathologies and interventions to create statistically robust, regulatorily compliant datasets that are valuable to payers, manufacturers, researchers, and providers. By focusing on primary data sourced directly from physicians and patients, RegenMed aims to solve fundamental inefficiencies in the healthcare system caused by fragmented and biased legacy data infrastructures. The company’s platform leverages inherent network effects to grow its reach and value as more healthcare professionals and institutions participate.

RegenMed generates recurring revenue by licensing its proprietary datasets and digital infrastructure to global clients across the healthcare ecosystem. Its future roadmap includes the development of AI models to derive insights from natural language records, the integration of blockchain for data security and incentives, and the tokenization of health records. Additional growth strategies involve geographic expansion and potential liquidity events such as regional joint ventures or direct listings. RegenMed positions itself as a “zero to one” company addressing systemic flaws in healthcare data collection and monetization through a scalable, tech-enabled model that prioritizes trust, security, and long-term stakeholder alignment.